ArticleThe Journal of clinical investigation2011

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.

Jessica J O'Konek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.